Psychosis secondary to traumatic brain injury (PSTBI) is reported to occur in anywhere from 4% to 8.9% of individuals who sustain traumatic brain injury (TBI) (Achte et al., 1991; Violon, 1988). Despite its rarity, PSTBI is of interest to clinicians and neuroscientists for three reasons: 1) there is usually a latency between the head injury and presentation of psychotic symptoms, thus the appearance of psychosis is often unexpected and puzzling; 2) there are diagnostic issues as some people who develop PSTBI have family histories of psychotic disorder, while many others do not; and 3) the disorder has conceptual relevance to understanding schizophrenia spectrum disorders (Fujii and Ahmed, 2001).
The purpose of this paper is threefold: 1) to review the literature on PSTBI; 2) to describe the shortcomings of the DSM-IV criteria for PSTBI; and 3) to provide a conceptual framework for understanding PSTBI.Review of PSTBI Literature
Onset. The age of onset for PSTBI appears to be highly variable, but most studies report means in the mid-20s to mid-30s (Fujii and Ahmed, 2001). Onset before 20 years of age appears to be relatively uncommon and may be associated with a more severe presentation of psychosis (Davison and Bagley, 1969).
The latencies between TBI and onset of psychosis are also variable. Although several researchers report means between four and five years, latencies can range from a few days to over 20 years (Achte et al., 1991; Fujii and Ahmed, 2001; Sachdev et al., 2001). Despite the wide range of latencies, studies suggest that about half of patients with PSTBI demonstrate symptoms within the first year, and roughly 72% of patients have symptoms within the first five years (Davison and Bagley, 1969; Fujii and Ahmed, 2002a).
There is some evidence suggesting that the duration of the latency between TBI and onset of psychosis may have clinical significance. Latencies of less than one year have been associated with diffuse injuries (Davison and Bagley, 1969), paranoid symptoms (Achte et al., 1991) and visual hallucinations (Fujii and Ahmed, 2002a). By contrast, patients with longer latencies before the onset of symptoms were found to have localized damage to the temporal lobe and presence of epilepsy (Davison and Bagley, 1969). In terms of prodromal symptoms, roughly half of patients with PSTBI demonstrate bizarre behaviors, affective instability and antisocial behaviors. Academic or vocational deterioration were reported in roughly one third of the patients, and about one third of patients also demonstrated social withdrawal (Sachdev et al., 2001).
Risk factors. Several risk factors for PSTBI have been reported. They include male gender, premorbid neurological abnormalities such as early head injury or neurological disorder (Fujii and Ahmed, 2001), previous psychological disturbance (Violon, 1988), family history of psychotic illness, or mental retardation (Achte et al., 1969). A family history of schizophrenia was reported in 2.9% to 18% of patients with PSTBI, thus appearring to be higher than in normal patients, but less than in patients with schizophrenia (Davison and Bagley, 1969).
Injury characteristics. Patients with either open- or closed-head injuries can develop PSTBI. Severity of injury, as measured by duration of loss of consciousness and posttraumatic amnesia, varies from mild to severe (Fujii and Ahmed, 2002a).
Epilepsy. The relationship between epilepsy--particularly temporal lobe epilepsy--and psychosis is well documented, and epilepsy is also a common comorbid condition in PSTBI (Lishman, 1998). Rates of epilepsy have ranged from 9% to 34% (Fujii and Ahmed, 2002a; Sachdev et al., 2001). Patients with open-head injuries appear to be more susceptible to comorbid epilepsy, with one study reporting a more than 2 to 1 ratio (Sachdev et al., 2001). There is some evidence that rates may actually be low estimates, as studies report that the percentage of patients with positive electroencephalogram findings are much higher, ranging up to 70% (Fujii and Ahmed, 2002a).
Presentation. Although PSTBI has been associated with many forms of delusions, including grandiose, referential, religious and Schneiderian symptoms, the most common symptoms are paranoid or persecutory delusions that are present in up to 80% of all patients (Fujii and Ahmed, 2002a). Auditory hallucinations were also common, with studies reporting 60% to 93% of patients presenting with this symptom (Fujii and Ahmed, 2002a; Sachdev et al., 2001). Visual hallucinations, negative symptoms and formal thought disorder were relatively rare, occurring in 8% to 32%, 15% to 22.2%, and 4.4% of patients, respectively (Fujii and Ahmed, 2002a; Sachdev et al., 2001).
Localization of injury. Localization data from different populations and methodologies, including imaging, EEG and lesion location, consistently report abnormalities in the temporal areas (Davison and Bagley, 1969; Fujii and Ahmed, 2002a). Less consistent, but also common, are abnormalities in the frontal lobes (Achte et al., 1969; Fujii and Ahmed, 2002a). There is no consistent finding for hemispheric laterality of lesions. Neuropsychologically, impairments in memory and executive functioning have been the most consistent finding (Fujii and Ahmed, 2002a; Sachdev et al., 2001).
Differential with schizophrenia. Fujii and Ahmed (2002a) reported several potentially discriminating variables between PSTBI and schizophrenia. Patients with PSTBI appear to have fewer negative symptoms and are more likely to present with positive findings on magnetic resonance imaging (MRI) and EEG. The most common MRI findings for PSTBI are focal abnormalities in frontal and temporal areas, while for schizophrenia, the most common abnormalities are enlarged ventricles. The most common EEG finding in PSTBI is temporal slowing versus frontal slowing for schizophrenia.
Course and treatment. There is much variability in course of illness and treatment responsiveness, with some patients demonstrating relatively short courses and others being more chronic. Chronicity was associated with premorbid schizoid personality (Davison and Bagley, 1969). A higher percentage of schizophrenic psychosis (63%) versus delusional disorders (40%) demonstrated a chronic course (Achte et al., 1991).
One study reported that neuroleptics were the most widely used treatment, followed by anticonvulsants and lithium(Drug information on lithium) (Fujii and Ahmed, 2002a). Considerations for selection of antipsychotic medication include increased sensitivity of the brain-injured to the sedating, anticholinergic and seizure threshold-lowering side effects of these drugs (Ahmed and Fujii, 1998). For example, chlorpromazine(Drug information on chlorpromazine) (Thorazine) has been reported to produce a delusional state along with worsening of cognition (Sandel et al., 1993). Although unsupported, some pharmacological strategies include the use of antikindling anticonvulsants for the treatment of late-onset psychosis and functional pharmacological approaches to treat specific functions such as attention and memory.